AAAAAA
Results:
1-15
|
Results: 15
Authors:
ROSELL R
CARDENAL F
MONTES A
ARTAL A
CARRATO A
LOMAS M
ALBEROLA V
BARNETTO I
MASSUTI B
LIEPA AM
Citation: R. Rosell et al., QUALITY-OF-LIFE IN NONSMALL CELL LUNG-CANCER PATIENTS RECEIVING GEMCITABINE (GEMZAR(R)) PLUS CISPLATIN OR ETOPOSIDE PLUS CISPLATIN, Annals of oncology, 9, 1998, pp. 403-403
Authors:
MARTIN C
FONT A
LEE JS
GONZALEZLARRIBA JL
ALBEROLA V
MONZO M
ROSELL R
Citation: C. Martin et al., PACLITAXEL RESISTANCE IN NONSMALL CELL LUNG-CANCER ASSOCIATED WITH BETA-TUBULIN GENE-MUTATIONS, Annals of oncology, 9, 1998, pp. 410-410
Authors:
DELASPENAS R
BUSQUIER I
MUNARRIZ J
LOPEZ A
LLORENTE R
ALBEROLA V
FRAU A
Citation: R. Delaspenas et al., PHASE-II STUDY OF GEMCITABINE, IFOSFAMIDE AND CISPLATIN (GIP) IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 424-424
Authors:
CARRATO A
ALBEROLA V
MASSUTI B
GALAN A
SANCHEZ JJ
GARCIAGOMEZ J
DIAZFERNANDEZ N
MEANA A
RODRIGUEZLESCURE A
GONZALVEZ ML
Citation: A. Carrato et al., COMBINATION OF GEMCITABINE (GEM) AND CARBOPLATIN (CARBO) AS FIRST LINE TREATMENT IN NONSMALL CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 431-431
Authors:
VIZCARRA E
LLUCH A
CIBRIAN R
JARQUE F
ALBEROLA V
BELLOCH V
GARCIACONDE J
Citation: E. Vizcarra et al., VALUE OF CA-15.3 IN BREAST-CANCER AND COMPARISON WITH CEA AND TPA - ASTUDY OF SPECIFICITY IN DISEASE-FREE FOLLOW-UP PATIENTS AND SENSITIVITY IN PATIENTS AT DIAGNOSIS OF THE FIRST METASTASIS, Breast cancer research and treatment, 37(3), 1996, pp. 209-216
Authors:
LECHEVALIER T
BRISGAND D
PUJOL JL
DOUILLARD JY
MONNIER A
RIVIERE A
CHOMY P
LEGROUMELLEC A
RUFFIE P
GOTTFRIED M
GASPARD MH
CHEVREAU C
ALBEROLA V
CIGOLARI S
BESSON F
MARTINEZ A
BESENVAL M
BERTHAUD P
TURSZ T
Citation: T. Lechevalier et al., RANDOMIZED STUDY OF NAVELBINE(R) AND CISP LATIN VERSUS VINDESINE AND CISPLATIN VERSUS NAVELBINE(R) ALONE IN 612 PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC), Bulletin du cancer, 83(5), 1996, pp. 385-394
Authors:
MAURIAC L
CARRION RP
ALBEROLA V
CALABRESI F
MICHEL RT
SANTOS R
WEHRLE E
ROYCE CM
Citation: L. Mauriac et al., RANDOMIZED TRIAL BETWEEN SELECTIVE AROMATASE INHIBITOR FORMESTANE ((R)LENTARON) VS TAMOXIFEN AS FIRST-LINE HORMONAL-THERAPY IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - CONFIRMATION OF BIOEQUIVALENCE IN SURVIVAL, European journal of cancer, 31A, 1995, pp. 365-365
Authors:
ALBEROLA V
ROSELL R
GONZALEZLARRIBA JL
MOLINA F
AYALA F
GARCIACONDE J
BENITO D
PEREZ JM
Citation: V. Alberola et al., SINGLE-AGENT TAXOL, 3-HOUR INFUSION, IN UNTREATED ADVANCED NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 6, 1995, pp. 49-52
Authors:
ROSELL R
GONZALEZLARRIBA JL
ALBEROLA V
MOLINA F
MONZO M
BENITO D
PEREZ LM
DEANTA JM
Citation: R. Rosell et al., SINGLE-AGENT PACLITAXEL BY 3-HOUR INFUSION IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER - LINKS BETWEEN P53 AND K-RAS GENE STATUS AND CHEMOSENSITIVITY, Seminars in oncology, 22(6), 1995, pp. 12-18
Authors:
LECHEVALIER T
BRISGAND D
DOUILLARD JY
PUJOL JL
ALBEROLA V
MONNIER A
RIVIERE A
LIANES P
CHOMY P
CIGOLARI S
GOTTFRIED M
RUFFIE P
PANIZO A
GASPARD MH
RAVAIOLI A
BESENVAL M
BESSEN F
MARTINEZ A
BERTHAUD P
TURSZ T
Citation: T. Lechevalier et al., RANDOMIZED STUDY OF VINORELBINE AND CISPLATIN VERSUS VINDESINE AND CISPLATIN VERSUS VINORELBINE ALONE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - RESULTS OF A EUROPEAN MULTICENTER TRIAL INCLUDING 612 PATIENTS, Journal of clinical oncology, 12(2), 1994, pp. 360-367
Authors:
LECHEVALIER T
PUJOL JL
DOUILLARD JY
ALBEROLA V
MONNIER A
RIVIERE A
LIANES P
CHOMY P
CIGOLARI S
BESSON F
BERTHAUD P
BRISGAND D
BURRIS HA
LIVINGSTON RB
GRALLA R
COLTMAN CA
Citation: T. Lechevalier et al., A 3-ARM TRIAL OF VINORELBINE (NAVELBINE) PLUS CISPLATIN, VINDESINE PLUS CISPLATIN, AND SINGLE-AGENT VINORELBINE IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER - AN EXPANDED ANALYSIS, Seminars in oncology, 21(5), 1994, pp. 28-34
Authors:
JARQUE F
LLUCH A
VIZCARRA E
MUNOZ M
ALBEROLA V
GARCIACONDE J
Citation: F. Jarque et al., QUANTITATIVE MONOCLONAL-ANTIBODY DETERMINATION OF ESTROGEN AND PROGESTERONE RECEPTORS IN HUMAN BREAST-CANCER - CORRELATION WITH THE RADIOLIGAND METHOD, Oncology, 51(5), 1994, pp. 435-439
Authors:
LLUCH A
AZAGRA P
CERVANTES A
MUNOZ M
ALBEROLA V
SANTABARBARA P
GARCIACONDE J
Citation: A. Lluch et al., PHASE-II TRIAL OF CISPLATIN AND ETOPOSIDE AS FIRST-LINE THERAPY IN METASTATIC BREAST-CARCINOMA, Oncology, 51(4), 1994, pp. 352-355
Authors:
LARRIBA JLG
ALBEROLA V
LIANES P
PANIZO A
CARRATO A
QUINTANA MAM
CARDENAL F
GRACIA JM
MOYANO A
DIAZRUBIO E
GARCIACONDE J
FUNES HC
MARTINEZ J
GUARAZ R
GUILLEM V
DELMURO XG
CUEVAS J
CRESPO C
MARTINEZ A
LECHEVALIER T
Citation: Jlg. Larriba et al., COMPARATIVE ACTIVITY OF NAVELBINE, NAVELB INE PLUS CISPLATIN, AND VINDESINE PLUS CISPLATIN IN THE THERAPY OF UNRESECTABLE NON-SMALL-CELL LUNG-CARCINOMA - RESULTS OF A MULTICENTRIC EUROPEAN RANDOMIZED TRIAL INCLUDING 612 PATIENTS, Revista Clinica Espanola, 194(11), 1994, pp. 953-959
Authors:
BOLUFER P
LLUCH A
MOLINA R
ALBEROLA V
VAZQUEZ C
PADILLA J
GARCIACONDE J
LLOPIS F
GUILLEM V
Citation: P. Bolufer et al., EPIDERMAL GROWTH-FACTOR IN HUMAN BREAST-CANCER, ENDOMETRIAL CARCINOMAAND LUNG-CANCER - ITS RELATIONSHIP TO EPIDERMAL GROWTH-FACTOR RECEPTOR, ESTRADIOL-RECEPTOR AND TUMOR TNM, Clinica chimica acta, 215(1), 1993, pp. 51-61
Risultati:
1-15
|